Bavarian Nordic A/S has upgraded its financial outlook for 2026 due to stronger-than-expected sales in its Travel Health segment, particularly driven by increased demand for rabies vaccines in the U.S. amid rising rabies exposure. The company now expects Travel Health revenue to reach approximately DKK 3.4 billion, up from the previous estimate of DKK 3 billion. Overall revenue is projected at around DKK 6.1 billion with an EBITDA margin of about 32%, improved from earlier forecasts. Other revenue assumptions remain unchanged, and the company maintains its focus on public preparedness and vaccine innovation.
Bavarian Nordic's upgraded financial outlook for 2026 is presented here with Pluang's Health sector data as of Oct 08, 2026 12:11 WIB. Among 100 priced Health-sector US stocks tradable on Pluang, 44 rose and 52 fell today. Notable movers include ADPT at USD 26.16 with a -2.75% change and 100% buy order activity, WGS at USD 69.57 with a -2.73% change, and ACB at USD 4.34 with a -2.69% change. The most notable figure is ADPT's full buy order activity on Pluang.
FLSmidth secured a DKK 360 million contract to supply advanced crushing and grinding equipment for a copper mine expansion in Northern Chile. The order includes the world's largest gyratory crusher, a large SAG mill, and three ball mills, with instal...
On October 8, 2026, Michelin repurchased 202,417 of its own ordinary shares at a weighted average price of €32.33 per share through over-the-counter transactions. The shares bought back are intended for cancellation, which can reduce the total number...
On October 8, 2026, Michelin executed a share buyback, purchasing 202,417 ordinary shares at a weighted average price of €32.33 per share. The shares were acquired through over-the-counter transactions involving several financial institutions and are...
FORVIA HELLA has secured two significant series orders for its EnergyCore solutions, including its first 3-in-1 high-voltage battery management system and a 48-volt PowerPack. These integrated systems reduce vehicle cost, complexity, weight, and spac...
Bavarian Nordic upgraded its full-year 2026 financial guidance due to stronger-than-expected sales in its Travel Health segment, particularly rabies vaccines in the U.S. Total revenue is now expected to reach approximately DKK 6,100 million, up from ...
